- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | Sandoz's Afqlir gains EC marketing authorisation for retinal diseases | ||
| Mo | AbbVie's Elahere wins European approval for certain ovarian cancers | ||
| Mo | FDA approves Syndax's Revuforj to treat leukaemia | ||
| Mo | AHA 2024: Plozasiran demonstrates promising Phase III results in FCS adults | ||
| Mo | AHA 2024: Lerodalciep provides promising results in open-label extension trial, LIBERATE-OLE | ||
| Mo | EMA's CHMP to approve BMS' Opdivo for colorectal cancer | ||
| Fr | FDA approves Azurity Pharmaceuticals' Danziten for CML treatment | ||
| Fr | Bavarian Nordic shares sink by 12% after mpox sales slump in Q3 | ||
| Fr | Patient experience in the spotlight at Clinical Trials in Oncology Europe 2024 | ||
| Fr | MSD secures worldwide license for LaNova's LM-299 | ||
| Fr | EMA's CHMP recommends Sanofi's Sarclisa approval for multiple myeloma | ||
| 14.11. | EMA committee rethinks stance and recommends Leqembi for Alzheimer's disease | ||
| 14.11. | Leading account and intent-based sales and marketing providers and technology solutions for the pharmaceutical industry | ||
| 14.11. | Kronos mulls 'strategic alternatives' after axing cancer drug development | ||
| 14.11. | Adaptimmune nears second sarcoma approval as Phase II trial hits endpoints | ||
| 14.11. | Metsera raises $215m in Series B round for weight loss candidates | ||
| 14.11. | FDA grants accelerated approval for PTC's AADC deficiency gene therapy | ||
| 14.11. | Huawei's top 10 construction principles for intelligent computing centre facilities | ||
| 14.11. | Valo Health appoints Brian Alexander as CEO | ||
| 14.11. | Perceptive eClinical Launches ClinPhone 5 | ||
| 14.11. | BioNTech signs agreement to acquire Biotheus | ||
| 13.11. | Syndax's stock sinks by 25% despite AML trial meeting primary endpoint | ||
| 13.11. | The development of novel drugs: the role of lyophilization | ||
| 13.11. | Intercept loses Ocaliva FDA full approval bid in rare liver disease | ||
| 13.11. | Health Canada approves GSK's Ojjaara for myelofibrosis in anaemia patients |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
